Worth reading
69In focus
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
-5588
¥ million (year-on-year decrease in operating profit)Wording
Conditional
How definitive the wording is.Results for this period
Interim period (second quarter)1 April 2026–30 September 2026ConsolidatedJapanese GAAPNet Sales178,676¥ millionYear on year +9.1%Progress 45.6%
Operating profit13,564¥ millionYear on year -29.2%Progress 39.9%
Ordinary income13,546¥ millionYear on year -28.5%Progress 39.8%
Net income attributable to owners of the parent9,981¥ millionYear on year -17.8%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥139.26
Financial position at period-end
Total assets590,478¥ million
of which net assets 307,509 ¥ millionEquity ratio 48.8%vs. prior year-end -0.9pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+15,712
Investment-14,679
Financials-1,445
Net change-412
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥46,070 million
Segment revenueChemical Products ¥52,723 million (YoY +0.7%), Cement ¥33,219 million (YoY +2.5%), Advanced Electronic Materials ¥46,557 million (YoY +9.3%), Life Science ¥29,049 million (YoY +50.6%), Environmental Business ¥2,592 million (YoY -3.3%)
Segment profitChemical Products ¥1,684 million (YoY -70.1%), Cement ¥4,255 million (YoY -12.0%), Advanced Electronic Materials ¥6,756 million (YoY -3.1%), Life Science ¥5,305 million (YoY +32.1%), Environmental Business ¥53 million (YoY -79.0%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥392,000 million (YoY +12.2%)
Operating profit¥34,000 million (YoY -8.2%)
Ordinary income¥34,000 million (YoY -11.0%)
Profit attributable to owners of the parent¥46,500 million (YoY +109.4%)
Net income per share¥648.8
Revision to Earnings ForecastNet Sales Not disclosed → ¥392,000 million / Operating profit Not disclosed → ¥34,000 million / Ordinary income Not disclosed → ¥34,000 million / Profit attributable to owners of the parent Not disclosed → ¥46,500 million
Annual Dividend Forecast¥120 → ¥140（+16.7%）
Shareholder Return PolicyDOE 4.0% (target for FY2030 under Medium-Term Management Plan 2030)
Factors Behind Changes in Business Performance
Revenue increased due to the consolidation of the Tokuyama Life Science Group and higher sales of semiconductor-related products, among other factors. Operating profit decreased due to higher raw material and fuel costs, among other factors. Selling, general and administrative expenses increased due to higher general and administrative expenses and logistics costs associated with the consolidation of the Life Science Group, among other factors.
Disclosure regarding the going concern assumption
None.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationAdditions: 0 companies; exclusions: 0 companies. There were no significant changes in the scope of consolidation during the period.
Material subsequent eventsEffective 1 October 2026, the domestic sales business for cement and solidifying materials will be transferred to a newly established company through an absorption-type company split, and all shares in that company will be transferred to TAIHEIYO CEMENT CORPORATION. The transfer price is ¥37 billion, and a gain on the sale of shares in an affiliated company of ¥32.071 billion is expected to be recorded. Following the transaction, an impairment loss of approximately ¥12 billion on property, plant and equipment for cement and solidifying materials manufacturing is expected to be recorded as an extraordinary loss in the third quarter of the fiscal year ending March 2027.
Impairment loss¥1 million (assets subject to impairment: Not disclosed)
Breakdown of extraordinary income (loss)Extraordinary income Gain on Sale of Property, Plant and Equipment ¥34 million, Gain on sale of investment securities ¥1,361 million, Subsidy Income ¥157 million, Other ¥52 million / Extraordinary loss Loss on sale of non-current assets ¥0 million, Impairment Losses ¥1 million, Losses from natural disasters ¥23 million, Loss on disposal of fixed assets ¥294 million, Loss on sale of investment securities ¥7 million
Depreciation and amortization¥11,756 million
Availability of Supplementary Financial Results MaterialsAvailable
Availability of Financial Results BriefingYes (for institutional investors and analysts)
Issued Shares at Period-End72,088,327 shares
Treasury Shares at Period-End976,836 shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026–30 September 2026 |
| Net Sales | ¥178,676 million (YoY +9.1%) |
| Operating profit | ¥13,564 million (YoY -29.2%) |
| Ordinary income | ¥13,546 million (YoY -28.5%) |
| Profit attributable to owners of the parent | ¥9,981 million (YoY -17.8%) |
| Net income per share | ¥139.26 |
| Equity ratio | End of the current fiscal period 48.8 / End of previous period 49.7 |
| Total assets | ¥590,478 million |
| Net assets | ¥307,509 million |
| Cash flows from operating activities | ¥15,712 million |
| Cash flows from investing activities | ¥-14,679 million |
| Cash flows from financing activities | ¥-1,445 million |
| Cash and cash equivalents at end of period | ¥46,070 million |
| Full-year earnings forecast | Net Sales ¥392,000 million (YoY +12.2%) / Operating profit ¥34,000 million (YoY -8.2%) / Ordinary income ¥34,000 million (YoY -11.0%) / Profit attributable to owners of the parent ¥46,500 million (YoY +109.4%) / Net income per share ¥648.8 |
| Revision to Earnings Forecast | Net Sales Not disclosed → ¥392,000 million / Operating profit Not disclosed → ¥34,000 million / Ordinary income Not disclosed → ¥34,000 million / Profit attributable to owners of the parent Not disclosed → ¥46,500 million |
| Annual Dividend Forecast | ¥120 → ¥140（+16.7%） |
| Shareholder Return Policy | DOE 4.0% (target for FY2030 under Medium-Term Management Plan 2030) |
| Segment revenue | Chemical Products ¥52,723 million (YoY +0.7%), Cement ¥33,219 million (YoY +2.5%), Advanced Electronic Materials ¥46,557 million (YoY +9.3%), Life Science ¥29,049 million (YoY +50.6%), Environmental Business ¥2,592 million (YoY -3.3%) |
| Segment profit | Chemical Products ¥1,684 million (YoY -70.1%), Cement ¥4,255 million (YoY -12.0%), Advanced Electronic Materials ¥6,756 million (YoY -3.1%), Life Science ¥5,305 million (YoY +32.1%), Environmental Business ¥53 million (YoY -79.0%) |
| Depreciation and amortization | ¥11,756 million |
| Impairment loss | ¥1 million (assets subject to impairment: Not disclosed) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on Sale of Property, Plant and Equipment ¥34 million, Gain on sale of investment securities ¥1,361 million, Subsidy Income ¥157 million, Other ¥52 million / Extraordinary loss Loss on sale of non-current assets ¥0 million, Impairment Losses ¥1 million, Losses from natural disasters ¥23 million, Loss on disposal of fixed assets ¥294 million, Loss on sale of investment securities ¥7 million |
| Disclosure regarding the going concern assumption | None. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Additions: 0 companies; exclusions: 0 companies. There were no significant changes in the scope of consolidation during the period. |
| Material subsequent events | Effective 1 October 2026, the domestic sales business for cement and solidifying materials will be transferred to a newly established company through an absorption-type company split, and all shares in that company will be transferred to TAIHEIYO CEMENT CORPORATION. The transfer price is ¥37 billion, and a gain on the sale of shares in an affiliated company of ¥32.071 billion is expected to be recorded. Following the transaction, an impairment loss of approximately ¥12 billion on property, plant and equipment for cement and solidifying materials manufacturing is expected to be recorded as an extraordinary loss in the third quarter of the fiscal year ending March 2027. |
| Availability of Supplementary Financial Results Materials | Available |
| Availability of Financial Results Briefing | Yes (for institutional investors and analysts) |
| Issued Shares at Period-End | 72,088,327 shares |
| Treasury Shares at Period-End | 976,836 shares |
| Factors Behind Changes in Business Performance | Revenue increased due to the consolidation of the Tokuyama Life Science Group and higher sales of semiconductor-related products, among other factors. Operating profit decreased due to higher raw material and fuel costs, among other factors. Selling, general and administrative expenses increased due to higher general and administrative expenses and logistics costs associated with the consolidation of the Life Science Group, among other factors. |
Items this document does not state (4)
Operating MarginPayout ratioRegional salesOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased due to the consolidation of the Tokuyama Life Science Group and higher sales of semiconductor-related products, among other factors. Operating profit decreased due to higher raw material and fuel costs, among other factors, while extraordinary gains and losses improved due to an increase in gains on the sale of investment securities accompanying the reduction of cross-shareholdings, among other factors.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.